GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a major focus in therapeutic studies, largely due to its remarkable impact on controlling conditions such as type 2 diabetes and obesity. Ongoing research have demonstrated that in addition to glucose regulation, GLP-1 agonists offer potential for heart health a… Read More